Report Detail
Global Pharmaceutical Grade Dydrogesterone Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4755832 |
- 13 October, 2026 |
- Global |
- 77 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Pharmaceutical Grade Dydrogesterone market size was valued at US$ 202 million in 2025 and is forecast to a readjusted size of US$ 266 million by 2032 with a CAGR of 4.1% during review period.
Pharmaceutical-grade dydrogesterone is an oral synthetic progestogen drug with a chemical name of 9β,10α-pregnane-4,6-diene-3,20-dione. Its molecular structure is highly similar to natural progesterone but has stronger biological activity. The drug simulates the effects of endogenous progesterone and specifically binds to the progesterone receptor (PR), exerting pharmacological effects such as regulating the secretory phase transformation of the endometrium, inhibiting estrogen overstimulation, and stabilizing the myometrium. It is mainly used clinically to treat gynecological diseases such as dysmenorrhea, endometriosis, secondary amenorrhea, dysfunctional uterine bleeding, premenstrual syndrome, and threatened abortion caused by insufficient endogenous progesterone. Its core advantages lie in its high bioavailability (up to 28%), potent progestin activity, and the characteristics of not inhibiting ovulation, making it one of the core drugs in the field of obstetrics and gynecology for regulating hormone balance, protecting pregnancy, and treating endometrial-related diseases.
As a key hormone drug for the treatment of diseases related to endogenous progesterone deficiency, pharmaceutical-grade dydrogesterone currently presents a market pattern dominated by original research drugs and accelerated breakthroughs in generic drugs. At the same time, technological innovation and expansion of clinical applications promote the sustainable development of the industry. The original research drug Dafutong has long occupied 99.86% of the domestic market share, but since the first generic drug of Auriate Pharmaceuticals was launched in 2023, companies such as Hangzhou Heze Kunyuan and Sichuan Kelun Pharmaceuticals have been approved one after another, breaking the global generic drug gap of more than 60 years and forming a "original research 1 + domestic 3" competition pattern. On the technical level, dydrogesterone has a high selectivity for progesterone receptors due to its unique "reversed" stereostructure, a bioavailability of 28%, and no estrogen, androgen and corticosteroid effects, fewer side effects, and is recommended by authoritative guidelines at home and abroad for endometriosis, threatened abortion, assisted reproductive technology and other scenarios. Market dynamics show that domestic sales will exceed 2 billion yuan in 2023, with an annual compound growth rate of more than 13%. With the breakthrough of generic drug technical barriers and the expectation of centralized procurement, the accessibility of drugs will be significantly improved. In the future, the industry will focus on formulation innovation (such as sustained release, nanotechnology), production process optimization (green pharmaceuticals, biocatalysis) and personalized treatment (genomics, biomarkers). At the same time, intelligent drug management and remote monitoring technologies will further improve patient compliance and promote the in-depth application of dydrogesterone in gynecology and reproductive fields.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade Dydrogesterone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Grade Dydrogesterone market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2021-2032
Global Pharmaceutical Grade Dydrogesterone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2021-2032
Global Pharmaceutical Grade Dydrogesterone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2021-2032
Global Pharmaceutical Grade Dydrogesterone market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade Dydrogesterone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade Dydrogesterone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Yangzhou Aurisco Pharmaceutical, Hangzhou Hezekunyuan Pharmaceutical, Sichuan Kelun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Grade Dydrogesterone market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Dydrogesterone Tablets (Single Progestin Drug)
Estradiol Dydrogesterone Tablets (Combined Preparation)
Market segment by Application
Gynecological Disease Treatment
Reproductive Medicine
Others
Major players covered
Abbott Laboratories
Yangzhou Aurisco Pharmaceutical
Hangzhou Hezekunyuan Pharmaceutical
Sichuan Kelun Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade Dydrogesterone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade Dydrogesterone, with price, sales quantity, revenue, and global market share of Pharmaceutical Grade Dydrogesterone from 2021 to 2026.
Chapter 3, the Pharmaceutical Grade Dydrogesterone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade Dydrogesterone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Grade Dydrogesterone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade Dydrogesterone.
Chapter 14 and 15, to describe Pharmaceutical Grade Dydrogesterone sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pharmaceutical Grade Dydrogesterone Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Dydrogesterone Tablets (Single Progestin Drug)
- 1.3.3 Estradiol Dydrogesterone Tablets (Combined Preparation)
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Pharmaceutical Grade Dydrogesterone Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Gynecological Disease Treatment
- 1.4.3 Reproductive Medicine
- 1.4.4 Others
- 1.5 Global Pharmaceutical Grade Dydrogesterone Market Size & Forecast
- 1.5.1 Global Pharmaceutical Grade Dydrogesterone Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Pharmaceutical Grade Dydrogesterone Sales Quantity (2021-2032)
- 1.5.3 Global Pharmaceutical Grade Dydrogesterone Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Abbott Laboratories
- 2.1.1 Abbott Laboratories Details
- 2.1.2 Abbott Laboratories Major Business
- 2.1.3 Abbott Laboratories Pharmaceutical Grade Dydrogesterone Product and Services
- 2.1.4 Abbott Laboratories Pharmaceutical Grade Dydrogesterone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Abbott Laboratories Recent Developments/Updates
- 2.2 Yangzhou Aurisco Pharmaceutical
- 2.2.1 Yangzhou Aurisco Pharmaceutical Details
- 2.2.2 Yangzhou Aurisco Pharmaceutical Major Business
- 2.2.3 Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Product and Services
- 2.2.4 Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Yangzhou Aurisco Pharmaceutical Recent Developments/Updates
- 2.3 Hangzhou Hezekunyuan Pharmaceutical
- 2.3.1 Hangzhou Hezekunyuan Pharmaceutical Details
- 2.3.2 Hangzhou Hezekunyuan Pharmaceutical Major Business
- 2.3.3 Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Product and Services
- 2.3.4 Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Hangzhou Hezekunyuan Pharmaceutical Recent Developments/Updates
- 2.4 Sichuan Kelun Pharmaceutical
- 2.4.1 Sichuan Kelun Pharmaceutical Details
- 2.4.2 Sichuan Kelun Pharmaceutical Major Business
- 2.4.3 Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Product and Services
- 2.4.4 Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Grade Dydrogesterone by Manufacturer
- 3.1 Global Pharmaceutical Grade Dydrogesterone Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Pharmaceutical Grade Dydrogesterone Revenue by Manufacturer (2021-2026)
- 3.3 Global Pharmaceutical Grade Dydrogesterone Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Pharmaceutical Grade Dydrogesterone by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Pharmaceutical Grade Dydrogesterone Manufacturer Market Share in 2025
- 3.4.3 Top 6 Pharmaceutical Grade Dydrogesterone Manufacturer Market Share in 2025
- 3.5 Pharmaceutical Grade Dydrogesterone Market: Overall Company Footprint Analysis
- 3.5.1 Pharmaceutical Grade Dydrogesterone Market: Region Footprint
- 3.5.2 Pharmaceutical Grade Dydrogesterone Market: Company Product Type Footprint
- 3.5.3 Pharmaceutical Grade Dydrogesterone Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Pharmaceutical Grade Dydrogesterone Market Size by Region
- 4.1.1 Global Pharmaceutical Grade Dydrogesterone Sales Quantity by Region (2021-2032)
- 4.1.2 Global Pharmaceutical Grade Dydrogesterone Consumption Value by Region (2021-2032)
- 4.1.3 Global Pharmaceutical Grade Dydrogesterone Average Price by Region (2021-2032)
- 4.2 North America Pharmaceutical Grade Dydrogesterone Consumption Value (2021-2032)
- 4.3 Europe Pharmaceutical Grade Dydrogesterone Consumption Value (2021-2032)
- 4.4 Asia-Pacific Pharmaceutical Grade Dydrogesterone Consumption Value (2021-2032)
- 4.5 South America Pharmaceutical Grade Dydrogesterone Consumption Value (2021-2032)
- 4.6 Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Pharmaceutical Grade Dydrogesterone Sales Quantity by Type (2021-2032)
- 5.2 Global Pharmaceutical Grade Dydrogesterone Consumption Value by Type (2021-2032)
- 5.3 Global Pharmaceutical Grade Dydrogesterone Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Pharmaceutical Grade Dydrogesterone Sales Quantity by Application (2021-2032)
- 6.2 Global Pharmaceutical Grade Dydrogesterone Consumption Value by Application (2021-2032)
- 6.3 Global Pharmaceutical Grade Dydrogesterone Average Price by Application (2021-2032)
7 North America
- 7.1 North America Pharmaceutical Grade Dydrogesterone Sales Quantity by Type (2021-2032)
- 7.2 North America Pharmaceutical Grade Dydrogesterone Sales Quantity by Application (2021-2032)
- 7.3 North America Pharmaceutical Grade Dydrogesterone Market Size by Country
- 7.3.1 North America Pharmaceutical Grade Dydrogesterone Sales Quantity by Country (2021-2032)
- 7.3.2 North America Pharmaceutical Grade Dydrogesterone Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Pharmaceutical Grade Dydrogesterone Sales Quantity by Type (2021-2032)
- 8.2 Europe Pharmaceutical Grade Dydrogesterone Sales Quantity by Application (2021-2032)
- 8.3 Europe Pharmaceutical Grade Dydrogesterone Market Size by Country
- 8.3.1 Europe Pharmaceutical Grade Dydrogesterone Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Pharmaceutical Grade Dydrogesterone Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Grade Dydrogesterone Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Grade Dydrogesterone Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Pharmaceutical Grade Dydrogesterone Market Size by Region
- 9.3.1 Asia-Pacific Pharmaceutical Grade Dydrogesterone Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Pharmaceutical Grade Dydrogesterone Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Pharmaceutical Grade Dydrogesterone Sales Quantity by Type (2021-2032)
- 10.2 South America Pharmaceutical Grade Dydrogesterone Sales Quantity by Application (2021-2032)
- 10.3 South America Pharmaceutical Grade Dydrogesterone Market Size by Country
- 10.3.1 South America Pharmaceutical Grade Dydrogesterone Sales Quantity by Country (2021-2032)
- 10.3.2 South America Pharmaceutical Grade Dydrogesterone Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Grade Dydrogesterone Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Grade Dydrogesterone Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Pharmaceutical Grade Dydrogesterone Market Size by Country
- 11.3.1 Middle East & Africa Pharmaceutical Grade Dydrogesterone Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Pharmaceutical Grade Dydrogesterone Market Drivers
- 12.2 Pharmaceutical Grade Dydrogesterone Market Restraints
- 12.3 Pharmaceutical Grade Dydrogesterone Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Pharmaceutical Grade Dydrogesterone and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pharmaceutical Grade Dydrogesterone
- 13.3 Pharmaceutical Grade Dydrogesterone Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pharmaceutical Grade Dydrogesterone Typical Distributors
- 14.3 Pharmaceutical Grade Dydrogesterone Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pharmaceutical Grade Dydrogesterone. Industry analysis & Market Report on Pharmaceutical Grade Dydrogesterone is a syndicated market report, published as Global Pharmaceutical Grade Dydrogesterone Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pharmaceutical Grade Dydrogesterone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
